# Medical Devices; Exemption From Premarket Notification; Class II Devices; Triiodothyronine Test System
> **Food and Drug Administration** · Final rule. · Published 2000-10-18 · Effective 2000-10-18 · 65 FR 62285
## Document
- **Document number:** 00-26740
- **Category:** fda-device
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 65 FR 62285
- **CFR reference:** 21 CFR 862
- **Publication date:** 2000-10-18
- **Effective date:** 2000-10-18
- **HHS docket:** Docket No. 00P-1280
## Abstract

The Food and Drug Administration (FDA) is publishing an order granting a petition requesting exemption from the premarket notification requirements for the triiodothyronine test system with certain limitations. This rule will exempt from premarket notification the triiodothyronine test system intended for measuring the hormone triiodothyronine in serum and plasma. FDA is publishing this order in accordance with procedures established by the Food and Drug Administration Modernization Action of 1997 (FDAMA).

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2000/10/18/00-26740/medical-devices-exemption-from-premarket-notification-class-ii-devices-triiodothyronine-test-system)
---
*AI Analytics · CC0 1.0*